- Report
- January 2024
- 80 Pages
United States
From €1331EUR$1,500USD£1,156GBP
- Report
- March 2022
- 157 Pages
Global
From €3195EUR$3,600USD£2,775GBP
- Report
- May 2023
- 105 Pages
Global
From €3500EUR$4,224USD£3,146GBP
- Report
- January 2024
- 80 Pages
Poland
From €1331EUR$1,500USD£1,156GBP
- Report
- February 2025
- 204 Pages
United States
From €5321EUR$5,995USD£4,621GBP

Uveitis is a medical condition that affects the uvea, the middle layer of the eye. It is characterized by inflammation of the uvea, which can lead to vision loss and other complications. In the context of optical, uveitis is a major cause of vision loss and can be treated with a variety of treatments, including topical and systemic medications, laser treatments, and surgery.
Uveitis is a growing market in the optical industry, as it is a common cause of vision loss and can be treated with a variety of treatments. Companies in the uveitis market include Bausch + Lomb, Novartis, Allergan, and Santen Pharmaceuticals. These companies offer a range of treatments for uveitis, including topical and systemic medications, laser treatments, and surgery. Show Less Read more